Covishield vaccination accepted in Switzerland, 7 EU countries
Nearly 95 per cent of people with cancer developed a good immune response to the Covid-19 mRNA vaccines three to four weeks after receiving their second dose, finds a new study co-authored by Indian-origin researchers.
The study, published in the journal Cancer Cell, indicated that among the 131 patients studied, 94 per cent developed antibodies to the coronavirus.
Seven high-risk patients did not.
Russia Coronavirus Vaccine
YouTube Grab/Sputnik We could not find any antibodies against the virus in those patients, said researcher Dimpy P. Shah from the University Of Texas Health Science Center at San Antonio.
94% of patients with cancer respond well to Covid vax: Study prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
94% of patients with cancer respond well to coronavirus vax: Study business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.